Key points
- Mounjaro costs ₹13,125 to ₹25,781 a month at MRP, depending on dose.
- Wegovy costs ₹5,660 to ₹16,400 a month; Poviztra ₹3,999 to ₹8,999.
- Generic semaglutide starts from about ₹1,300 a month since the patent expired in March 2026.
- Prices checked 5 November 2026. Next update early December 2026.
GLP-1 injection prices in India this month
Monthly cost at MRP for one month of weekly doses, from the lowest to the highest strength. The cost you pay depends on the dose your doctor prescribes.
| Medicine | Maker | Approved in India for | MRP per month |
|---|---|---|---|
| Mounjaro KwikPen Tirzepatide | Eli Lilly | Weight management and type 2 diabetes | ₹13,125 to ₹25,781* |
| Wegovy Semaglutide | Novo Nordisk | Weight management | ₹5,660 to ₹16,400* |
| Poviztra Semaglutide | Novo Nordisk, sold by Emcure | Weight management | ₹3,999 to ₹8,999* |
| Ozempic Semaglutide | Novo Nordisk | Type 2 diabetes | ₹5,660 to ₹9,100* |
| Noveltreat Semaglutide (generic) | Sun Pharma | Weight management | About ₹3,600 to ₹8,000 (launch)* |
| Obeda pen Semaglutide (generic) | Dr Reddy's | Type 2 diabetes | About ₹4,200 (launch)* |
| Semasize Semaglutide (generic) | Indian generic maker | Type 2 diabetes and weight management | ₹1,500 to ₹3,500* |
| Semaglutide vials Semaglutide (generic) | Natco, Glenmark and others | Mainly type 2 diabetes at launch | From about ₹1,300* |
* Maximum retail prices (MRP) in India, checked 5 November 2026. Shown as a guide only: prices change and may differ when you buy. Lean Life does not sell medicines. All of these medicines need a doctor's prescription.
Mounjaro price by dose
| Dose (weekly) | KwikPen MRP, one month |
|---|---|
| 2.5 mg | ₹13,125 |
| 5 mg | ₹16,406 |
| 7.5 mg | ₹20,625 |
| 10 mg | ₹20,625 |
| 12.5 mg | ₹25,781 |
| 15 mg | ₹25,781 |
Lilly's 2.5 mg and 5 mg strengths are also sold as single-dose vials, at ₹3,281 and ₹4,102 a vial. Four vials cost about the same as one KwikPen. Read our Mounjaro guide.
Wegovy price by dose
| Dose (weekly) | MRP, one month |
|---|---|
| 0.25 mg | ₹5,660 |
| 0.5 mg | ₹8,100 |
| 1 mg | ₹9,100 |
| 1.7 mg | ₹12,750 |
| 2.4 mg | ₹16,400 |
Ozempic uses the same pens at diabetes doses: ₹5,660 at 0.25 mg, ₹8,100 at 0.5 mg and ₹9,100 at 1 mg. Read our Wegovy guide.
Semaglutide tablets
| Medicine | Maker | Approved for | MRP |
|---|---|---|---|
| Rybelsus | Novo Nordisk | Type 2 diabetes | ₹2,972 to ₹3,628 per 10 tablets* |
| Obeda tablets | Dr Reddy's | Type 2 diabetes | ₹99 to ₹225 a tablet* |
* Maximum retail prices (MRP) in India, checked 5 November 2026. Shown as a guide only: prices change and may differ when you buy. Lean Life does not sell medicines. All of these medicines need a doctor's prescription.
What a first year costs
Doses start low and rise every 4 weeks, so the first year costs less than 12 months at the top dose. These estimates assume standard dose steps and MRP.
| Medicine | First 12 months at MRP |
|---|---|
| Generic semaglutide (Semasize, up to 2.4 mg) | About ₹35,300* |
| Wegovy (up to 2.4 mg) | About ₹1,66,810* |
| Mounjaro (up to 10 mg) | About ₹2,35,781* |
Doctor consultations, blood tests and dietitian support are extra, wherever you are treated. Work out your own first-year cost.
What changed in 2026
- 20 March 2026: Novo Nordisk's main semaglutide patent in India expired. Sun Pharma, Dr Reddy's, Natco, Glenmark and other companies launched generic semaglutide within days, from about ₹1,300 a month.
- 1 April 2026: Novo Nordisk set lower prices for Ozempic and Wegovy in India.
- 3 April 2026: Emcure cut Poviztra's prices; the starting dose fell by 55%, to ₹3,999 a month.
- May 2026: Dr Reddy's launched semaglutide tablets for type 2 diabetes at ₹99 a tablet.
- October 2026: An expert panel of India's drug regulator asked Novo Nordisk for more data before approving Wegovy tablets for weight management.
- Looking ahead: Eli Lilly is reported to be planning an India launch of its oral obesity medicine, Foundayo (orforglipron), in 2027. Tirzepatide has no generic version in India.
How to read these prices
- MRP is the maximum a pharmacy can charge. Many sell for less.
- Generic semaglutide is the same molecule as Wegovy and Ozempic, but not every brand is approved for weight management. Check the approval with your doctor.
- Cheaper isn't always better value: the right medicine and dose depend on your health, your goals and how you tolerate it.
- Buy only from a licensed pharmacy, with a prescription. Pens and vials sold without a prescription, or through social media, may be fake or badly stored.
Using these figures?
You're welcome to quote this tracker. Please credit and link to it as: Lean Life GLP-1 Price Tracker, India, November 2026 (leanlifeclinic.me/glp1-price-tracker-india). Journalists can find facts and contacts on our press page.
Need help choosing?
A Lean Life doctor can tell you which medicine and dose suit you, and what your treatment is likely to cost overall. We don't sell medicines, so our advice isn't tied to any brand.
Questions
How much does Mounjaro cost in India?
₹13,125 a month at the 2.5 mg starting dose, rising to ₹25,781 at 12.5 mg and 15 mg (MRP, November 2026).
What is the cheapest GLP-1 medicine in India?
Generic semaglutide vials, from about ₹1,300 a month at MRP. Not every generic is approved for weight management, so ask your doctor which suits you.
Is Wegovy cheaper than Mounjaro?
Yes, at every dose. Wegovy runs from ₹5,660 to ₹16,400 a month, and Mounjaro from ₹13,125 to ₹25,781.
Is there a generic Mounjaro in India?
No. Tirzepatide, the medicine in Mounjaro, is still under patent in India and has no generic version.
How often is this tracker updated?
Every month. We check each price against current MRP listings and manufacturers' announcements, and note any change.
References
- Mounjaro price in India: MRP and monthly cost, PharmEasy, updated 1 November 2026
- Wegovy price in India: MRP and monthly cost, PharmEasy, updated 1 November 2026
- Novo Nordisk India sets new prices for Ozempic and Wegovy from 1 April 2026, Indian Pharma Post
- Emcure Pharmaceuticals press release: Poviztra price reduction, 2 April 2026
- Rs 325 to 4,200 a month: Dr Reddy's, Sun Pharma, Glenmark kick off generic semaglutide price war, ThePrint, March 2026
- Sun Pharma launches semaglutide injection under brand names Noveltreat and Sematrinity, BioSpectrum India, March 2026
- Dr Reddy's launches DCGI-approved semaglutide injection Obeda for type 2 diabetes, BioSpectrum India, March 2026
- Manufacturer press release: Semasize semaglutide launch, March 2026
- Rybelsus price in India, PharmEasy, August 2026
- Dr Reddy's launches oral semaglutide tablets at Rs 99 per pill in India, Business Today, 20 May 2026
- Wegovy tablets for weight management: CDSCO panel seeks more data from Novo Nordisk, Medical Dialogues, 21 October 2026
- Eli Lilly may launch oral obesity drug Foundayo in India in 2027, Free Press Journal, 2 October 2026




